SALONPAS Drug Patent Profile
✉ Email this page to a colleague
When do Salonpas patents expire, and when can generic versions of Salonpas launch?
Salonpas is a drug marketed by Hisamitsu Pharm Co and is included in one NDA. There are two patents protecting this drug.
This drug has twenty patent family members in sixteen countries.
The generic ingredient in SALONPAS is menthol; methyl salicylate. There are eighteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the menthol; methyl salicylate profile page.
DrugPatentWatch® Generic Entry Outlook for Salonpas
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be January 3, 2030. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SALONPAS?
- What are the global sales for SALONPAS?
- What is Average Wholesale Price for SALONPAS?
Summary for SALONPAS
| International Patents: | 20 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Clinical Trials: | 1 |
| Patent Applications: | 76 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SALONPAS at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for SALONPAS
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for SALONPAS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Scilex Pharmaceuticals, Inc. | Phase 1 |
US Patents and Regulatory Information for SALONPAS
SALONPAS is protected by two US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of SALONPAS is ⤷ Sign Up.
This potential generic entry date is based on patent ⤷ Sign Up.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting SALONPAS
Adhesive preparation
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Adhesive preparation
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hisamitsu Pharm Co | SALONPAS | menthol; methyl salicylate | PATCH;TOPICAL | 022029-001 | Feb 20, 2008 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Hisamitsu Pharm Co | SALONPAS | menthol; methyl salicylate | PATCH;TOPICAL | 022029-002 | Nov 5, 2012 | OTC | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Hisamitsu Pharm Co | SALONPAS | menthol; methyl salicylate | PATCH;TOPICAL | 022029-001 | Feb 20, 2008 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Hisamitsu Pharm Co | SALONPAS | menthol; methyl salicylate | PATCH;TOPICAL | 022029-002 | Nov 5, 2012 | OTC | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for SALONPAS
When does loss-of-exclusivity occur for SALONPAS?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Australia
Patent: 07279643
Patent: Adhesive preparation
Estimated Expiration: ⤷ Sign Up
Brazil
Patent: 0712396
Patent: preparação de adesivo
Estimated Expiration: ⤷ Sign Up
Canada
Patent: 52220
Patent: PREPARATION ADHESIVE (ADHESIVE PREPARATION)
Estimated Expiration: ⤷ Sign Up
China
Patent: 1442993
Patent: Adhesive preparation
Estimated Expiration: ⤷ Sign Up
European Patent Office
Patent: 47845
Patent: PRÉPARATION ADHÉSIVE (ADHESIVE PREPARATION)
Estimated Expiration: ⤷ Sign Up
Hungary
Patent: 47985
Estimated Expiration: ⤷ Sign Up
Japan
Patent: 2008016077
Patent: 貼付剤
Estimated Expiration: ⤷ Sign Up
Patent: 30423
Estimated Expiration: ⤷ Sign Up
Malaysia
Patent: 9142
Patent: ADHESIVE PREPARATION
Estimated Expiration: ⤷ Sign Up
Mexico
Patent: 08014574
Patent: PREPARACION ADHESIVA. (ADHESIVE PREPARATION.)
Estimated Expiration: ⤷ Sign Up
New Zealand
Patent: 2705
Patent: ADHESIVE PREPARATION containing methyl salicylate
Estimated Expiration: ⤷ Sign Up
Russian Federation
Patent: 41649
Patent: АДГЕЗИВНЫЙ ПРЕПАРАТ (ADHESIVE PRODUCT)
Estimated Expiration: ⤷ Sign Up
Patent: 08144958
Patent: АДГЕЗИВНЫЙ ПРЕПАРАТ
Estimated Expiration: ⤷ Sign Up
Singapore
Patent: 4034
Patent: ADHESIVE PREPARATION
Estimated Expiration: ⤷ Sign Up
South Korea
Patent: 1420450
Estimated Expiration: ⤷ Sign Up
Patent: 090035474
Patent: ADHESIVE PREPARATION
Estimated Expiration: ⤷ Sign Up
Spain
Patent: 55027
Estimated Expiration: ⤷ Sign Up
Taiwan
Patent: 14299
Estimated Expiration: ⤷ Sign Up
Patent: 0817013
Patent: Adhesive preparation
Estimated Expiration: ⤷ Sign Up
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering SALONPAS around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| European Patent Office | 2047845 | PRÉPARATION ADHÉSIVE (ADHESIVE PREPARATION) | ⤷ Sign Up |
| South Korea | 101420450 | ⤷ Sign Up | |
| Canada | 2652220 | PREPARATION ADHESIVE (ADHESIVE PREPARATION) | ⤷ Sign Up |
| South Korea | 20090035474 | ADHESIVE PREPARATION | ⤷ Sign Up |
| Singapore | 174034 | ADHESIVE PREPARATION | ⤷ Sign Up |
| Australia | 2007279643 | Adhesive preparation | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
